Distinct Dopamine D2 Receptor Antagonists Differentially Impact D2 Receptor Oligomerization (original) (raw)
Dopamine D2 receptors dimers: how can we pharmacologically target them?
Luca Giovannini
Current neuropharmacology, 2017
View PDFchevron_right
Increased baseline occupancy of D2 receptors by dopamine in schizophrenia. Proc Natl Acad Sci U S A
R GG
Proceedings of the National Academy of Sciences
View PDFchevron_right
Increased baseline occupancy of D2 receptors by dopamine in schizophrenia
T. Cooper, M. Laruelle, Lawrence Kegeles
Proceedings of the National Academy of Sciences, 2000
View PDFchevron_right
Dopamine D2 heteroreceptor complexes and their receptor-receptor interactions in ventral striatum: Novel targets for antipsychotic drugs
Wilber Romero-Fernandez, Michael Di Palma, Sergio Tanganelli, Dasiel O Borroto-Escuela, Luigi Agnati
2014
View PDFchevron_right
D2 Dopamine Receptor Homodimerization Is Mediated by Multiple Sites of Interaction, Including an Intermolecular Interaction Involving Transmembrane Domain 4
Ryan Rajaram
Biochemistry, 2003
View PDFchevron_right
Receptor-Protein Interactions Mediated by the Fourth Transmembrane of D2R Can Be Altered by Treatment with Antipsychotics
craig irving
2017
View PDFchevron_right
Dopamine D2 Receptor Supersensitivity as a Spectrum of Neurotoxicity and Status in Psychiatric Disorders
Cynthia Crawford
The Journal of pharmacology and experimental therapeutics, 2018
View PDFchevron_right
Visualization and ligand-induced modulation of dopamine receptor dimerization at the single molecule level
Peter Gmeiner
Scientific reports, 2016
View PDFchevron_right
Inhibition of cell surface expression by mutant receptors demonstrates that D2 dopamine receptors exist as oligomers in the cell
Huda Akil
Molecular pharmacology, 2000
View PDFchevron_right
Mechanism of action of clozapine in the context of dopamine D1-D2 receptor hetero-dimerization--a working hypothesis
Maciej Kusmider
Pharmacological reports : PR
View PDFchevron_right
Structural Determinants of Pharmacological Specificity Between D1 and D2 Dopamine Receptors
Curtiss Durand
Molecular Pharmacology, 2005
View PDFchevron_right
Dopamine D2S and D2L receptors may differentially contribute to the actions of antipsychotic and psychotic agents in mice
Dubravka Hranilovic
Molecular Psychiatry, 2002
View PDFchevron_right
Dopamine D2 Receptor Occupancy and Clinical Effects
Takefumi Suzuki
Journal of Clinical Psychopharmacology, 2011
View PDFchevron_right
In schizophrenia, some dopamine D2-like receptors are still elevated
Albert Gjedde
Psychiatry Research: Neuroimaging, 1996
View PDFchevron_right
Dopamine D2 and D4 receptor heteromerization and its allosteric receptor–receptor interactions
Amina Woods, Wilber Romero-Fernandez, Dasiel O Borroto-Escuela, Luigi Agnati, Kjell Fuxe
Biochemical and Biophysical Research Communications, 2011
View PDFchevron_right
Targeted D Dopamine Receptors: Implications for Drug Discovery and Therapeutic Development
George B Stefano
2013
View PDFchevron_right
Potential Mechanisms for Why Not All Antipsychotics Are Able to Occupy Dopamine D3 Receptors in the Brain in vivo
Dr. István Laszlovszky
Frontiers in Psychiatry
View PDFchevron_right
Linking the Family of D2 Receptors to Neuronal Circuits in Human Brain: Insights into Schizophrenia
Jeffrey Joyce
Neuropsychopharmacology, 1997
View PDFchevron_right
The role of D1–D2 receptor hetero-dimerization in the mechanism of action of clozapine
Maciej Kusmider
European Neuropsychopharmacology, 2008
View PDFchevron_right
Dopamine D 2 receptor partial agonists display differential or contrasting characteristics in membrane and cell-based assays of dopamine D 2 receptor signaling
Shaun Jordan
Progress in Neuro-psychopharmacology & Biological Psychiatry, 2007
View PDFchevron_right
Evidence against dopamine D1/D2 receptor heteromers
Kai C Sonntag
Molecular Psychiatry, 2015
View PDFchevron_right
History of the Discovery of the Antipsychotic Dopamine D2 Receptor: A Basis for the Dopamine Hypothesis of Schizophrenia
Bertha Madras
Http Dx Doi Org 10 1080 0964704x 2012 678199, 2013
View PDFchevron_right
Bias analyses of preclinical and clinical d2 dopamine ligands: studies with immediate and complex signaling pathways
Val Watts
The Journal of pharmacology and experimental therapeutics, 2015
View PDFchevron_right
A Molecular Basis for Selective Antagonist Destabilization of Dopamine D3 Receptor Quaternary Organization
John Pediani
Scientific reports, 2017
View PDFchevron_right
In vitro biochemical evidence that the psychotomimetics phencyclidine, ketamine and dizocilpine (MK-801) are inactive at cloned human and rat dopamine D 2 receptors
Shaun Jordan
European Journal of Pharmacology, 2006
View PDFchevron_right
A peptide targeting an interaction interface disrupts the dopamine D1-D2 receptor heteromer to block signaling and function in vitro and in vivo: effective selective antagonism
Ahmed Hasbi
The FASEB Journal, 2014
View PDFchevron_right
Psychosis pathways converge via D2High dopamine receptors
Tomiki Sumiyoshi
Synapse, 2006
View PDFchevron_right
Atypical and typical antipsychotic drug interactions with the dopamine D2 receptor
Erik Hjerde, Ingebrigt Sylte
European Journal of Medicinal Chemistry, 2005
View PDFchevron_right
The dopaminergic stabilizers pridopidine (ACR16) and (−)OSU6162 display dopamine D 2 receptor antagonism and fast receptor dissociation properties
Clas Sonesson
European Journal of Pharmacology, 2010
View PDFchevron_right
Functional Homomers and Heteromers of Dopamine D2L and D3 Receptors Co-exist at the Cell Surface
Clotilde Mannoury la Cour
Journal of Biological Chemistry, 2012
View PDFchevron_right
Possible implications of the dopamine D3 receptor in schizophrenia and in antipsychotic drug actions
Jorge-Aurelio Diaz
Brain Research Reviews, 2000
View PDFchevron_right